Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biosimilar, Generic and Rx User Fees Rely On Different Adjusters For Needed Appropriations

Jan 23 2012

• By Derrick Gingery

Related Content

FDA’s Generic Drug Office Goes On Diet Before Swallowing User Fees

Nov 28 2011

PDUFA Formula Could Better Incorporate Present Economic Conditions

Apr 18 2011

User Fee Triggers Require Care In Unfriendly Budget Environment, Ventimiglia Says

Dec 05 2011

Generic Facility Fee Unlikely To Be Charged Until A Few Months After GDUFA Implementation

Dec 19 2011

Biosimilar User Fee Agreement Reached, But Will Require Appropriations Boost

Sep 22 2011

FDA Funding Bill In Senate Gives Generic Drugs More, But Commissioner Less

Aug 02 2010

PDUFA V Action Heats Up On Hill With House Hearings In February

Jan 12 2012

FDA, Industry Haggle Over Price For New User Fee Deal

Jan 16 2012

FDA Reorganization Adds "Directorate" Layer, But Sharpens Agency's Focus

Jul 18 2011

Additional Topics

United States Drug Approval Standards Legislation BioPharmaceutical

More from United States

More from North America

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window